Abstracts

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children’s Hospital of Rabat, 2022-2023

Abstract

Introduction: Morocco was selected as a pilot site for the WHO launched the Global Initiative for Childhood Cancer GICC and a childhood cancer control strategy was set up to reduce mortality and the 2030 survival target was set at 80%. This study analyzes the mortality causes for children treated at the Pediatric Hemato-Oncology Center in Rabat.

Methodology: We included all cancer patients admitted for cancer and who died over the period from January 1st, 2022, to December 31, 2023. A descriptive analysis was performed on the causes and circumstances of death, the epidemiological and clinical characteristics of the patients.

Results: A total of 51 deaths were recorded during the period. The primary cause of death was tumor progression (61%), followed by treatment-related toxicity (31%). 45% of deaths occurred over the weekend, on public holidays, and on Mondays. October accounted for 18% of deaths. Urban patients appeared to have a higher mortality rate than rural patients. The majority of deaths (29%) occurred within the first month following diagnosis.

A total of 51 deaths were recorded out of a population of 429 patients. The main cause of death was tumor progression (61%), followed by treatment-related toxicity (31%). The most commonly reported cancer was leukemia, followed by lymphomas (20%) and neuroblastomas (18%). The sex ratio favored males, with a ratio of 1.22. The median survival time after diagnosis was less than one year for 76% of the patients.

Conclusion: The study highlighted that deaths were mainly associated with tumor progression followed by treatment-related toxicity (31%). These results suggest that the causes are likely linked to patients presenting at advanced disease stages, underscoring the importance of early diagnosis. This study serves as a crucial starting point for improving clinical practices, enhancing patient stratification, and better managing treatment toxicity to achieve the country’s 2030 objective.

How to Cite

Ansari NE, Isfaoun Z, Lakhrissi M, Kababri ME, Kili A, Khorassani ME, et al. Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children’s Hospital of Rabat, 2022-2023. OncoDaily Med J. 2025. doi:10.69690/ODMJ-018-0425-2837